Animesh Pardanani
Mayo Clinic(US)
Publications by Year
Research Areas
Myeloproliferative Neoplasms: Diagnosis and Treatment, Acute Myeloid Leukemia Research, Chronic Myeloid Leukemia Treatments, Eosinophilic Disorders and Syndromes, Kruppel-like factors research
Most-Cited Works
- → Safety and Efficacy of INCB018424, a JAK1 and JAK2 Inhibitor, in Myelofibrosis(2010)1,158 cited
- → MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients(2006)1,032 cited
- → DIPSS Plus: A Refined Dynamic International Prognostic Scoring System for Primary Myelofibrosis That Incorporates Prognostic Information From Karyotype, Platelet Count, and Transfusion Status(2010)1,024 cited
- → Philadelphia-Negative Classical Myeloproliferative Neoplasms: Critical Concepts and Management Recommendations From European LeukemiaNet(2011)826 cited
- → Mutations and prognosis in primary myelofibrosis(2013)741 cited
- → Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosis(2014)716 cited
- → Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study(2013)658 cited
- → Role of JAK2 in the pathogenesis and therapy of myeloproliferative disorders(2007)585 cited
- → Circulating Interleukin (IL)-8, IL-2R, IL-12, and IL-15 Levels Are Independently Prognostic in Primary Myelofibrosis: A Comprehensive Cytokine Profiling Study(2011)583 cited
- → Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors(2009)568 cited